Post-Transplant Cyclophosphamide Improves Outcomes of ALL Patients Receiving Allogeneic Hematopoietic Cell Transplantation (HSCT) Compared to Standard GVHD Prophylaxis

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Melhem Solh, Stephanie Gregory, Jacob Bartlet, Lucy Solh, Scott R. Solomon, Joseph E. Maakaron, H. Kent Holland, Lizamarie M Bachier, Asad Bashey
DOI: 10.1016/j.jtct.2025.12.165
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Acute Lymphoblastic Leukemia research Immunodeficiency and Autoimmune Disorders

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S114–S114
Publication date
1 February 2026
Language
EN